Agilon Health (AGL) Cost of Revenue (2020 - 2026)

Agilon Health has reported Cost of Revenue for 7 years, with the latest figure at $367.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 914.56% year-over-year to $367.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.3 billion (up 121.17% YoY), and the FY2025 full-year result was $6.0 billion, up 74623.82% from the prior year.
• Cost of Revenue for Q1 2026 stood at $367.7 million, down from $5.9 billion in the prior quarter.
• The five-year high for Cost of Revenue was $5.9 billion in Q4 2025, with the low at -$63.5 million in Q4 2024.
• Historically, Cost of Revenue has averaged $992.8 million across 5 years, with a median of $367.7 million in 2026.
• Annual changes were most pronounced in 2024 — Cost of Revenue plunged 101.61% — and 2025, when it surged 9377.3%.
• Agilon Health's Cost of Revenue stood at $847.1 million in 2022, then surged by 364.85% to $3.9 billion in 2023, then sank by 101.61% to -$63.5 million in 2024, then surged by 9377.3% to $5.9 billion in 2025, then plunged by 93.76% to $367.7 million in 2026.
• The last three Cost of Revenue figures came in at $367.7 million (Q1 2026), $5.9 billion (Q4 2025), and $33.7 million (Q3 2025), per Business Quant data.